Search

Author/Creator Coopmans, Eva C

1. Efficacy and safety of switching to pasireotide in acromegaly patients controlled with pegvisomant and somatostatin analogues: PAPE extension study. Issue 5 (November 2018)

Authors:
Muhammad, Ammar; Coopmans, Eva C; Delhanty, Patric J D; Dallenga, Alof H G; Haitsma, Iain K; Janssen, Joseph A M J L; van der Lely, Aart J; Neggers, Sebastian J C M M
Journal:
European journal of endocrinology
Issue:
Volume 179:Issue 5(2018)
Page Start:
269
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Excellent response to pasireotide therapy in an aggressive and dopamine-resistant prolactinoma. Issue 2 (August 2019)

Authors:
Coopmans, Eva C; van Meyel, Sebastiaan W F; Pieterman, Kay J; van Ipenburg, Jolique A; Hofland, Leo J; Donga, Esther; Daly, Adrian F; Beckers, Albert; van der Lely, Aart-Jan; Neggers, Sebastian J C M M
Journal:
European journal of endocrinology
Issue:
Volume 181:Issue 2(2019)
Page Start:
K21
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. T2-signal intensity, SSTR expression, and somatostatin analogs efficacy predict response to pasireotide in acromegaly. Issue 6 (June 2020)

Authors:
Coopmans, Eva C; Schneiders, Joppe J; El-Sayed, Nour; Erler, Nicole S; Hofland, Leo J; van der Lely, Aart-Jan; Petrossians, Patrick; Potorac, Julia; Muhammad, Ammar; Neggers, Sebastian J C M M
Journal:
European journal of endocrinology
Issue:
Volume 182:Issue 6(2020)
Page Start:
595
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗